Key result
Cardiac biomarkers hs-troponin and natriuretic peptides improve CV risk stratification in non-cardiac surgery.
Why the study?
Despite improvements in perioperative management, postoperative complication rates remain high in non-cardiac surgery, necessitating more accurate preoperative risk stratification.
Does the measurement of cardiac-specific biomarkers improve risk stratification for cardiovascular complications in patients undergoing non-cardiac surgery?
Does the measurement of cardiac-specific biomarkers improve risk stratification for cardiovascular complications in patients undergoing non-cardiac surgery?
Preoperative and postoperative assessment of modern cardiac-specific biomarkers (troponins and natriuretic peptides) provides critical incremental value in stratifying the risk of perioperative cardiovascular complications in non-cardiac surgery.
Despite significant tactic’s improvements of perioperative management of patients undergoing non-cardiac surgery, there is still a high incidence of postoperative complications. So more accurate risk stratification is necessary before surgery in order to possibly reduce such risk. In addition to assessing the risk associated with surgery, the risk associated with the patient, which may be due to the presence of certain diseases, primarily cardiovascular, is also assessed. There are currently evidences of the validity of determining the level of biomarkers in the blood in certain groups of patients during operations not related to cardiac intervention, which makes it possible to clarify the scope of necessary diagnostic interventions in preparation for surgery, as well as to diagnose complications of heart disease in the postoperative period.
No takes yet. Share an insight, caveat, or question.
Alimova et al. (2024) conducted a review in Patients undergoing non-cardiac surgery. Measurement of cardiac-specific biomarkers (high-sensitivity troponin and natriuretic peptides) was evaluated. Measurement of modern cardiac-specific biomarkers such as high-sensitivity troponin and natriuretic peptides improves cardiovascular risk stratification in patients undergoing non-cardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: